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Impairment of colour contrast sensitivity and 
neuroretinal dysfunction in patients with 
symptomatic HIV infection or AIDS 
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Thomas Beminger, Volker K1auss, Frank D Goebel 
Abstract 
Ophthalmie and neurological complications 
are frequent findings in patients witb AIDS. 
Little is DOwn about neuroretinal dysfunetioD 
in patients with HIV infectioo. Tbe purpose of 
this study was to measure and evaluate colour 
visioo in patients with HIV infectioo or AIDS. 
Colour contrast sensitivity tests were per-
formed 00 75 patients (ISO eyes) in differenl 
slages of HIV infection. A highly sensitive 
computer graphics system was used 10 
measure tritan, deutan, and protan colour 
cODtrasl thresbolds. PatienlS were c1asslfied 
into three c1inical groups: (a) asymplomatic 
HIV infection, (b) Iymphadenopathy syn-
drome or AIDS-related complex, and (c) 
AIDS. OveraU, tritaD (p<O·OOOI), deutaD 
(p=O·()()3), and protan (p=O·OO9) colour coo-
trast sensitivities were significandy impaired in 
patients witb HIV infection compared with 
normal controls. Colour thresholds in patieDts 
with asymptomatic HIV infectioo (mean tritan 
tbresbold: 4·33; deutan: 4·41; protan: 3·97) 
were not impaired compared with normal coo-
trols. Colour vision was sligbdy impaired in 
patients witb lympbadeoopathy syndrome 
or AIDS-related complex (trilan: 6·25 
(p< O·OOOI); deutao: 4·99 (p=O·02); prolan: 
4·45 (p=O,05». In patients with AIDS the 
impairment was eveo more marked (tritan: 
7·66 (p< O·OOOI); deutao: 5·15 (p<O·OOO9); 
prolan: 4·63 (p=O·OO4». Analysis of covari-
ance controlling for age demonstrated a dose 
association betweeo impairment of tritan 
colour contrast seositivity and progreSSiOD 
of HIV disease (p< O·OOOl). FoUowiog 
KöUner's rule, our stady suggests tbat neuro-
retinal dysfunetion QCcurs in patients witb 
symptomatic HIV iofectioo or AIDS. Tbis is 
empbasised by tbe finding that tbe relative 
impairmenl in tritan vision compared witb 
deutaniprotaD visioD migbt reßect the diß'er-
ence in the Dumber of cones or receptive fields. 
Measurement of tritan colour contrast sensi-
tivity appears to be an appropriate and easily 
applicable method to delect early neuroretinal 
dysfunetion in patieots with HIV disease. 
(Sr J Opluhalmoll993; 77: 716-720) 
A new method for testing colour Vision was 
recently described by Arden el al' when stimuli 
of varying colour contrast sensitivities are 
generated on a television monitor using a 
computer system. It has been shown that this 
system is able 10 detect and quantify changes in 
colour contrast sensitivity below the threshold of 
other commonly used colour lest systems.' j This 
computer graphics system was used to measure 
colour contrast sensitivity in patients infected 
with HIV-I in the different stages of the 
disease. 
Neurophysiologieal , neurologieal , and neuro-
ophthalmie deficits have been reponed in 
patients with AIDS .... 1 Recently, Quieeno et all 
reponed deficits in eolour vision in patients with 
AIDS, but no specifie colour axis of error was 
identified. There is areport suggesting that 
neurophysiological abnormalities QCcur in 
patients with asymptomatic HIV infection, but 
visual evoked potentials with pattern stimuli are 
noted to be normal in those patients.· The 
purpose of tbis smdy was to measure the colour 
contrast sensitivity in all patients with HIV 
infeetion and normal controls. In addition , the 
results from patients with asymptomatic HIV 
infection , patients with symptomatic HIV infec-
tion (without AIDS), and patients with AIDS 
were compared. 
Patieols, material, and metbods 
SUBJECTS 
The study group consisted of75 outpatients (150 
eyes) with HIV infection seeking consultation 
at the department of ophthalmology of the 
University of Munieh. Those patients with 
visual acuity below 0·8 with best correction, 
hereditary deut-/prot-/tritanomalia, hereditary 
deut-/prot-/tritanopia, diabetes mellitus, bistory 
or use of dideQxyinosme or dideoxycytidine, 
AIDS dementia, or opponunistic infections of 
the eye or the brain at the time of the study were 
excluded. Visual acuity was detennined , and 
patients were refracted on an autorefractor if 
visual acuity was < 1·0. Informed consent was 
obtained from all patients. All 75 patients were 
male, 68 reponed homo-Ibisexual orientation, 
and seven patients heterosexual orientation. No 
patient reported the use of illegal drugs. The 
mean age was 40·3 yens with an SD of9·6 (age 
range from 24 10 62 years). 
81000 TESTS AND CLASSIFICATION OF HIV 
INFEOION 
The sera from all patients were positive for 
HIV-I or HIV-II antibodies as delermined by a 
licensed enzyme linked inununosorbent assay 
(Boehringer, Ingelheim). Western blot immuno-
electrophoresis showed HIV-I infection in a11 
patien1s. S1agmg was done according to the 
Walter Reed and the Centers for Disease Control 
(CDC) classifications. '0" Patients in Walter 
Reed 1 were redassified as patients with asymp-
tOmatic HIV infection (CDC classification 11). 
Patients in Walter Reed 2 to Walter Reed 5 wcrc 
redassified as Iymphadenopathy syndrome! 
AIOS-related complex (CDC dassification 111 , 
IVA, or IVB). Patients in Waller Reed 6 or 
Walter Reed 2/K to Walter Reed 6/K or Waller 
Reed 2fN tO Walter Reed 6IN were reclassified as 
AIDS (COC classification IVC or IVO). The 
control group consistcd of 70 male visitors or 
patients (140 eyes) who were HIV antibody 
negative with no known disease or abnormality 
01" the anterior or po5terior segment of the eye . 
The mean age of the control group was 39·6 
years (SO 11·9; age range 14 tO 71 ycars). 
COLOUR CONTRAST SENSITlVlTY 
The computer graphics system originally des-
cribed by Arden er 01 in 1988' was used with the 
modmcations described by Arden er 01 in 1991 .' 
In shorl, a monitor with a 90 Hz refresh rate, and 
dot pitch of 0·31 mm wilh a 980"760 pixel 
resolution (non-interlaced) was uscd 10 display 
the colours. A 100 MHz card, based on Hitachi 
ACRTC chip set with single pixel scrolling , pan 
and zoom facilities, and foregroundlbackground 
display with alternate sereens was used with a 
Brooktree '24-bit ' palene. A personal computer 
(Compac Inc) with an 80286 CPU and an 80287 
mathematical co-processor was uscd with soft-
ware programs wrinen in 'C'. 
The stimuli composed of letters were dis-
played for 200 msls in the centre of a large 
uniform field. The letters were 8·1 cm high and 
traced from a standard optOtype. The relative 
luminance ofthe blue:green and red:green guns 
was measured firstly by heterochromatic flicker 
photOmetry. Then, colour contrast thresholds 
were determined along protanldeutan and tritan 
colou r confusion axes, which were orthogonal 
tO eaeh other in 'Commission Internationale 
J'Edairage' COIOUf space. The eolour contrast 
thresholds were measured by a modified binary 
search scheme starting with a stimulus slightly 
above the mean threshold for most people (in this 
study the value= 12). The sub;eCl then indicated 
whether detection had occurred. When the 
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COIOUf stimulus was deteCled , the signal pre-
scnted became the new upper bound and half the 
contrast became the lower bound (value=6). 
When the stimulus value 12 was not detected, 
value 12 became the lowcr bound and value 24 
the upper bound. Thresholds were measured to 
within 0·3 (whicb is the limit for the precision of 
the analogue to digital converter systcm).' The 
stage of the discase was not known to the 
investigators. 
STATISTICAL ANALYSIS 
The primary issue of the study was to detect an 
impairmcnt in at least one of the three colour 
axes of colour contrast scnsitivity between 
patients with HIV infection and normal controls. 
A multiple significance level of a = 0'05 was 
aecepted. The Bonferroni adjustment was used 
to determine the critical p value for a single one 
sided Student's t test: PC'i,=0·05/3=0·0167. '11l 
Another issue addresscd in this study was to 
establisb an association between the severity of 
the HIV infection and impairment of colour 
contrast scnsitivity. The severily of thc diseasc 
was staged according to the three categories 
mentioned above. A corre1ation of eolour con-
trast sensitivity with age has been reported. ' 
Therefore, analysis of covariance with age as a 
covariate was performed." Numerical one sidcd 
p values are reported for those calculations and 
the resuhs were interpreted with the intention of 
looking for 'near regular patterns'. 'I Correlations 
were calculated using the Pearson correlation 
coefficient method. Statistical analysis was car-
ried out on an lBMlPS2 using the SPSS/PC+ 
V2.0 Program (SPSS Inc; SPSS·PC+ V2.0 Base 
Manual. SPSS Incorporation, Chicago, 1988). 
Results 
Overall comparisons revealed devated thres-
holds of colour contrast sensitivity in alJ thrce 
colour axes (Table I). The mean value for the 
Iritan threshold was 6·65 (S O 2'52) in palients 
with HIV infeetion. The difference from the 
normal controls was highly significant (mean 
z valuc: 1·29; p<O·OOOI ). The 95% confidence 
interval for the difference from the normal 
controls after z transformation was 1·09 to 1·49. 
Thc mean thresholds for deutan and protan were 
4·99 (1'26) and 4'49 (1'2 1). The difference from 
normal controls was significant for the deutan 
(mean z value: 0'32; p= 0'OO3) and the protan 
axes (mean z value: 0'28; p= O·(}09). Tbe 95% 
confidencc intcrvals for the difference after 
z transformation were 0'11 to 0·53 and 0·08 
10 0-49, respectively. Thirty five per cent of 
paticnts with HIV infection presented with 
abnormal responses (outside 2 SO above the 
mean value; calculated for the normal controls) 
for lritan vision, Eleven per cent of patients 
with HIV infection prescnted with abnormal 
responses for protan vision, and 12% for deutan 
vision. The [ritan threshold was four times 
higher than deutan (4'0:1) and protan (4'6: 1) 
thresholds. 
Comparisons between the three c1inical 
groups of HIV infection suggest a dose associa-
tion between progression of the disease and 
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elevation of tritan threshold (p<O'OOOI ) (Table 
1; Fig I). Tritan contrast sensitivity in patients 
with asymptomatic HIV infection (mean thres-
hold 4· 33 (SO 1'02» was not impaired compared 
with that in normal controls. However, tbe mean 
tritan threshold was significantly elevated in 
patients with lymphadenopathy syndrome or 
AIDS relaled complex (6'25 (1-82), p<O'OOOI); 
in patients with AIDS, this elevation was even 
more marked (7'66 (2-93), p<O-OOOI). No 
patient with asymptomatic HIV infection, 28% 
of patieots with LAS or ARe, and 51% of 
patieDts with AIDS prescnted with abnormal 
responses for tritan vision. Dc:utan (4'41 (1'18» 
and protan (3'97 (I- 32» thresholds in patients 
with asymptomatic HIV infectiOD did not differ 
from those in normal controls, but there was 
a tendency towards a thresbold elevation in 
patients witb lympbadenopathy syndrome or 
AIDS related complex (deutan: 4·99 (1'23), 
p=0'02; protan: 4'45 (l'18), p=0·05). Both 
thresholds were similarly elevated in patients 
witb AIDS (deutan: 5·15 (l'29), p<O-OOI; 
protan: 4·63 (l·33). p<O'OOl) wben compared 
with tbe normal values. No patient with asymp-
tomatic HIV infection, 3% of patients with LAS 
or ARC, and 20% of patients with AIDS pre-
sented with abnormal responses for protan 
vision. Similarly, no patient with asymptomatic 
HIV infection, 5% of patients with LAS or ARC, 
and 21% of patients with AIDS presented with 
abnormal responses for deutan vision. 
Tbe correlation coefficients of the colour con-
trast sensitivity with age were r=O-36 for tritan, 
r=0'23 for deutan, and r=0-20 for protan. The 
correlation coefficient between deutan and 
protan ws wal: r=0·91. Tbe correlation ooeffici-
ents of tritan axes with protan and deutan axes 
were r= 0'52 and r=0'61, respectively. 
Discussion 
This study shows a decrease in colour contrast 
sensitivity in patients with symptomatic HIV 
infection and AIDS. However, colour vision was 
normal in patients with asymptomatic HIV 
infectiOD. Tbe decrease in colour vision was 
primarily evident for tritan coloue contrast sensi-
tivity, which was highly reduced in patients with 
symptomatic HIV infection and AIDS . The 
impairment of tritan vision increased as the 
disease progressed from symptomatic HIV infec-
tion to AIDS_ The impairment in deutan and 
protan colour contrast sensitivity was less than 
that in tritan contrast sensitivity; but the de6cits 
in deutan and protan vision were very evident 
among patients with AIDS. After traIlsfonna-
tion of the resuhs in z values, tritan colour 
contrast sensitivity was impaired about four 
times more than the deutan and protan colour 
contrast sensitivity. 
KöUner" demonstrated in 1912 that altera-
tions of the optic nerve are accompanied by 
deficits in protan vision, whereas alterations of 
the neuroretina are accompanied by deficits in 
tritan vision_ An impairment of tritan vision was 
the prominent finding in oue study_ Following 
KöUner's roJe, we conclude tbat dysfunction of 
the neuroretina is seen in patients with Iympba-
denopathy syndrome, AIDS related complex, or 
AIDS. 
Neurophysiologica.l studies have shown that 
the total number of tritan photoreceptors is 
lower compared with deutan or protan photo-
recc:ptors. and tbat tbe relative frequency of the 
different cones is 1-0:2-5:4-1 (tritan:protan: 
deutan) in primates. " 11 As tritan receptors are 
less numerous. damage to the neuroretina causes 
alterations of tritan vision fiest before alterations 
of deutan or protan vision occur _ '0 One might 
speculatethat the 4:1 ratio found for impairment 
of tritan and protanldeutan sensitivity might be 
related to the difference in the number of cones 
of blue-yellow and red-green receptive fields 
because. if damage occurs on retinal level. the 
relative impairment might be quantitatively 
reLated to a difference in the numbee of cones or 
recc:ptive fields of the different colour systems_ 
However, other eIplanations for the difference 
in the magnitude of impairment of tritan and 
protanldeutan sensitivity include a more limited 
response range and a higher fragility of the tritan 
colour vision system compared with the protanI 
deutan coloUf vision system. lt 
Tbere was a high correlation between deutan 
and protan colour contrast sensitivity, which 
should be eIpected for physiologica.l reasons. lO 
Colour vision in humans is organised in [Wo 
systems on the postreceptoral retinal level, the 
blue/yellow (S cone) and the redlgrttn (L cone 
and M cone) systems, and both systems are 
organised in recc:ptive fidds. Tberefore, the high 
correlation between protan and deutan thres-
holds can be interpreted as an indication of the 
reliability of OUf results. 
Sc:veral aspects of the results of OUf study 
should be discussed. Firstly. the pattern of 
association of colour vision impairment with 
progression of the disease was similar for the 
three COIOUfaxes, even if impainnent of deutan 
and protan colour vision was not as prominent as 
tbat of tritan coloUf vision. Sc:condly. possible 
changes due to drug misuse were circumvented 
by our eIclusion criteria. Thirdly. it is unlikely 
tbat an undetected opportunistic infection of the 
eye was present. since no patient developed 
retina! or system.ic cytomegalovirus infection 
or other opportunistic ocular infections within 
2 months after testing for colour contrast 
sensitivity. Founhly. the association between 
impainnent of colour cOntrast sensitivity and 
progression of the disease was not related to age. 
The corre1ations between colour contrast sensi-
tivity and age in our study were similar to the 
findings by Arden et al.' Analysis of covariance 
with age as covariate demonstrated thal the 
impairment of colour contrast sensitivity was 
most closely re1ated to the severity of the disease. 
This is corroborated by the finding of a faster 
progression of the disease in older patients, and a 
tendency towards a more severe disease in older 
patients due to the longer asymptomatic period 
of HIV infection. 11>1 Lasuy, the impairment of 
colour vision is not related to the homosexual 
orientation of most of our patients, since in the 
asymptomatic patients 00 decrease of colour 
contrast sensitivity was shown. 
It shouJd be mentioned that the degree of the 
underlying colour vision impairment in patients 
with lymphadenopathy syndrome, AIDS related 
complex, and AIDS is very low. Thereforc, the 
impairment of colour vision in patients with 
Iymphadenopathy syndrome, AIDS related 
complex, or AIDS has no implicatioos for daily 
life - for example, car driving. 
Our findings are in accordance with several 
e1ectrophysiological sludies done on the eye." 1) 
No ocular electrophysiological changes were 
found in patients with asymptomatic HIV infec-
tioo .' Reduction of the amplitudes in the pattern 
e1ectroretinogram combined with P50 latency 
suggests an alteration of the oeuroretina in 
patients with AIDS." The resuJts of the present 
study are also in accordance with papers rcport-
ing on clinical neurological complications in 
abom 35% of patients with AIDS,!) and on 
neuropathological changes seen in up to 88% of 
autopsy brains., .. /Ii The data of the present study 
are not totally in accordance with arecent study 
reporting that oeuro-ophthalmic abnormalities 
are presem in ooly a minority (8%) of patiems 
with AIDS.II Recently, Quiceno et all were able 
to show a decrease in colour discrimination in 
patients with AIDS, but 00 significant decrease 
was found for patiems with AIDS related com-
plex, and no particu1ar ws of elTor was identi-
fied applying the Famswonh-Munsell lOO-hue 
test. 
Several mechanisms of damage to the neuro-
retina might be responsible for the dysfunction 
of the colour contrast sensitivity in patients with 
HIV infection. In patiems with diabetic retina-
pathy an alteration of colour vision was reported 
by different authors, and tritan vision seems to 
be more impaired when compared with protan 
and deutan vision in patients with diabetic 
retinal microvascuJopathy."''' Therefore, micro-
vascular changes known in patients with 
HIV disease sbouJd be considered. HIV-related 
retina! microvascuJopathy is the most common 
ocuJar finding in severe HIV infection (with a 
frequency of50% to 80% in patients with AIDS). 
The former causes retinal damage presenting 
as cotton wool spots or haemorrhages upon 
ophthalmoscopic examination.J1- ·· According to 
retinal fiuorescein angiography and pathological 
studies there is evidence that cotton wool spots in 
patients with AIDS might be caused by micro-
vascular abnormalities,)I.Il l1 and retinal micro-
vascular alterations were observed in patients 
with AIDS or symptomatic HIV disease by 
fluorescein angiography . .Il · Recently, we were 
able to demonstrate a c10se association between 
the occurrence of cotton wool spots and cerebral 
hypoperfusion, as well as between cotton wool 
spots and cognitive deficits. l9 " We favour the 
hypothes:is that the deficits in colour contrast 
sensitivity are primarily rdated 10 HIV related 
retinal microvasculopathy. Other pathogenetic 
factors also need to be discussed. HIV has been 
detected in the retina, in endothelial cells, in 
microglial cells, and in multinucleated giam 
cells. " .... Moreover, metabolic alterations may 
also be important in patients with symptomatic 
HIV infection ...... It is possible that the neuro-
retinal dysfunction in patients with symptomatic 
HIV infection is caused by a combination of 
these factors. 
Our results suggest that neuroretinal damage 
occurs in patients with symptomatic HIV infec-
tion or AIDS. Measurement of tritan colour 
contrast sensitivity might be an appropriate and 
easily applicable method for the measurement of 
early neuroretinal dysfunction in patients with 
HIV infection. The underlying pathogeruc 
mechanisms need to be elucidated. 
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